Before the advent of penicillin, acute haemorrhagic encephalitis was described as a complication of parenteral arsphenamine treatment for syphillis.'2 Occupational exposure to toxic amounts of arsenic in the workplace has most commonly resulted in the appearance of peripheral neuropathy, rash, or gastrointestinal symptoms. The following case describes acute encephalopathy after occupational exposure to arsenic.
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A 50 year old chemical plant engineer presented with delirium. At the age of 22 while in the armed forces he had been briefly admitted to hospital with a psychiatric illness that he described as being related to the stresses of his job. For over 20 years he had worked intermittently with a smelting process in which antimony is purified from antimony ore; industrial hygiene monitoring of the process had detected sulphur, arsenic, copper, iron, and lead in the ore and contaminating the finished product. Five years before admission, with complaints of diarrhoea, cough, rash, and feelings of anger and suspicion, he had consulted a physician who measured urine arsenic at 21 pg/l (normal 0-20); the symptoms resolved without treatment over several days, and he returned to work. He had no history of alcoholism or recent drug use. His wife of 17 years had noted a gradual change in his personality over several years accompanied by difficulties with memory and marked by episodes of suspiciousness and marital conflict.
During the week before presentation he had spent several days working within the smelting furnace, failing to use the required respiratory protection. On the day before presentation, he experienced severe nausea, vomiting, and diarrhoea, and awoke from sleep with hallucinations, disorientation, and agitation. He sought medical attention and did not return to work; his mental status gradually improved. One month after the end of his exposure, he again became agitated and was admitted to the hospital where examination was remarkable only for delirium, which rapAccepted I July 1985 idly resolved. He continued to exhibit a rapidly fluctuating mental state with prominent agitation and emotional lability. Blood counts, serum electrolytes, calcium, phosphorus, glucose, BUN, T-4, and electrocardiogram results were normal; a CT scan of the head showed only a slightly asymmetric right lateral ventricle. An EEG two days after admission showed only mild slowing of the alpha rate, considered to be within normal limits. Urine arsenic was 41 ig/l (normal occupational exposure <30 ig/1). Urinary antimony, lead, and selenium were within expected limits for those occupationally exposed. No urine mercury could be detected, and urine manganese was within normal limits. Arsenic in the nuchal hair was 40 4ug/g in the distal shafts (normal 0-03 to 0-32.ug/g) and 5-1 pg/g in the proximal shafts. Nerve conduction studies of the feet detected no sensory deficit. His mental state improved steadily over several days before the initiation of chelation treatment During a nine day course of chelation with BAL, urine arsenic excretion fell to undetectable levels for several days, then returned to levels seen before the start of chelation. His mental state continued to improve during treatment. After his discharge from the hospital, his wife noted persistent memory loss and more pronounced changes in personality and behaviour since the episode of delirium. Three weeks after the end of BAL treatment he became severely agitated without delirium. The agitation resolved rapidly within 24 hours, before the initiation of a second course of BAL chelation. Psychological testing detected deficits in his ability to learn new information, by contrast with a good performance when previously learned information was required for the task.
Chronic occupational arsenic exposure can occur through inhalation, ingestion, or absorption through the skin, and has most frequently been associated with chronic mixed motor and sensory polyneuropathy after prolonged low level exposure. Epidemiological studies have shown an increased incidence of skin and lung cancer in those exposed.
Clinicopathological correlation of arsenic intoxi- 
